Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms

NCT06731946 is registered in ClinicalTrials.gov with Yibin Fang as lead sponsor.

NCT NCT06731946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms
Lead sponsor
Yibin Fang
Phase
Observational
Overall status
Active, not recruiting
Start date
November 29, 2024
Completion date
December 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial arterial aneurysm